Arkolith/Insider Trading/ESPR/Form 4

Koenig Sheldon L.

President and CEO, DirectorEsperion Therapeutics, Inc. (ESPR) · full profile →Form 4 · filed Sep 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$26K
Net Open-Market Flow
-$26K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 17, 2024Sell(S)15K$1.80$26K752K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-24-040787) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML